135 related articles for article (PubMed ID: 881645)
1. A model-independent proof of Dost's law of corresponding areas.
Vaughan DP
J Pharmacokinet Biopharm; 1977 Jun; 5(3):271-6. PubMed ID: 881645
[No Abstract] [Full Text] [Related]
2. Proof of the general validity of Dost's law of corresponding areas.
Nüesch E
Eur J Clin Pharmacol; 1973 Jun; 6(1):33-43. PubMed ID: 4764371
[No Abstract] [Full Text] [Related]
3. [Pharmacokinetic aspects relevant to biopharmaceutics].
Segre G
Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
[No Abstract] [Full Text] [Related]
4. [Biological availability of drugs].
Holovkin VO
Farm Zh; 1979; (2):20-5. PubMed ID: 456507
[No Abstract] [Full Text] [Related]
5. History of pharmacokinetics.
Wagner JG
Pharmacol Ther; 1981; 12(3):537-62. PubMed ID: 7025032
[No Abstract] [Full Text] [Related]
6. Pharmacokinetics and bioavailability.
Wagner JG
Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
[No Abstract] [Full Text] [Related]
7. [Application of pharmacokinetics in clinical pharmacology and biopharmaceutics].
Xi NZ
Yao Xue Xue Bao; 1983 Feb; 18(2):151-60. PubMed ID: 6613595
[No Abstract] [Full Text] [Related]
8. Bioavailability and pharmacokinetic analysis of drug responding systems.
Smolen VF
Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
[No Abstract] [Full Text] [Related]
9. [Bioavailability and biopharmaceutics].
Colombo BM; Colombo MM; De Fusco R
Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980
[No Abstract] [Full Text] [Related]
10. [Pharmacokinetic models].
Dahl S
Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373
[No Abstract] [Full Text] [Related]
11. [A pharmacokinetic function for galenics].
Dost FH
Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699
[No Abstract] [Full Text] [Related]
12. Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity.
Lalka D; du Souich P; McLean AJ; Gibaldi M
J Pharm Sci; 1978 Apr; 67(4):591-2. PubMed ID: 641784
[No Abstract] [Full Text] [Related]
13. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.
Smolen VF
J Pharmacokinet Biopharm; 1976 Aug; 4(4):337-53. PubMed ID: 978396
[No Abstract] [Full Text] [Related]
14. Bioavailability and bioequivalence.
Skelly JP
J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):539-45. PubMed ID: 977792
[No Abstract] [Full Text] [Related]
15. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
Jaminet F
J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
[No Abstract] [Full Text] [Related]
16. Literature growth in pharmacokinetics.
Boxenbaum H
J Pharmacokinet Biopharm; 1982 Jun; 10(3):335-48. PubMed ID: 7175703
[TBL] [Abstract][Full Text] [Related]
17. [Biologic availability of drugs in humans and animals].
Wichliński L
Pol Tyg Lek; 1975 Dec; 30(50):2111-2. PubMed ID: 1197106
[No Abstract] [Full Text] [Related]
18. The simulation of the elimination process for a substance injected into the blood stream.
Hallberg D; McLean A
Acta Med Scand; 1973; 194(3):173-9. PubMed ID: 4746525
[No Abstract] [Full Text] [Related]
19. [Methods of studying drug substance absorption].
Makarov VA
Farmatsiia; 1980; 29(2):71-5. PubMed ID: 6991295
[No Abstract] [Full Text] [Related]
20. Bioavailability from pharmaceutical dosage forms.
Stenlake JB
Analyst; 1974 Dec; 99(1185):824-37. PubMed ID: 4462405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
